Vertex Pharmaceuticals Inc. buy Wells Fargo & Company
Start price
10.01.25
/
50%
€398.50
Target price
10.01.26
€447.72
Performance (%)
-3.30%
Price
12:41
€385.35
Summary
This prediction is currently active. With a performance of -3.30%, the BUY prediction for Vertex Pharmaceuticals Inc. by Wells_Fargo___Compan is down slightly. This prediction currently runs until 10.01.26. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vertex Pharmaceuticals Inc. | -1.509% | -1.509% |
| iShares Core DAX® | 0.734% | 1.458% |
| iShares Nasdaq 100 | -2.686% | -0.146% |
| iShares Nikkei 225® | -2.261% | -2.729% |
| iShares S&P 500 | -1.346% | 0.467% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target lowered by analysts at Wells Fargo & Company from $555.00 to $460.00. They now have an "overweight" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€380.75
10.12.25
10.12.25
€442.18
10.12.26
10.12.26
1.97%
12:41
12:41
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€325.60
06.08.25
06.08.25
€397.62
06.08.26
06.08.26
19.24%
12:41
12:41
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€439.95
24.06.24
24.06.24
€516.65
24.06.25
24.06.25
-11.44%
25.06.25
25.06.25
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€383.95
06.02.24
06.02.24
€502.09
06.02.25
06.02.25
21.15%
07.02.25
07.02.25